Aharon Gil 4

What Happened

• Aharon Gil, a director of Neuraxis, reported two acquisitions (Form 4, transaction code A) on 2026-04-28: 12,304 shares issued directly to him and 221,917 shares issued to an entity in which he has an indirect interest, for a total of 234,221 shares acquired. No cash price is reported because these shares were issued as dividends on Series B preferred stock rather than bought in the open market.

Key Details

• Transaction date: 2026-04-28; Form 4 filed: 2026-04-30 (appears timely, within the usual 2-business-day window).
• Consideration/price: N/A — shares issued as dividend on Series B preferred stock.
• How share counts were determined: the dividend shares were calculated by dividing accrued unpaid 8.5% cumulative dividends by $2.38 per share (per filing).
• Shares owned after transaction: not specified in the Form 4.
• Beneficial-ownership note: the reporting persons disclaim beneficial ownership except to their pecuniary interest; the 221,917 shares relate to Rosalind Master Fund L.P., in which the reporting person has indirect ownership (see filing footnotes).

Context

• These were dividend-based issuances from Series B preferred stock (an award/acquisition), not open-market purchases or sales. Such non-cash issuances reflect conversion of accrued preferred dividends into common shares and do not by themselves indicate a buy/sell sentiment.